First report of major endpoint reduction in patients with biopsy-proven NASH
Leader plans to collaborate with other medical disciplines for the benefits of patients with obesity.
Findings are from a large cohort study in patients with type 2 diabetes and obesity
New study finds that the average patient can expect to lose an additional 3.5kg on canagliflozin
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Weight fluctuations after year one less important than percentage of weight loss in year one, study suggests